Viking Therapeutics (VKTX) Exchange Rate Effect (2022 - 2026)
Viking Therapeutics (VKTX) posted Exchange Rate Effect of $16000.0 for Q1 2026, up 77.78% sequentially from $9000.0 in Q4 2025, and up 1500.0% YoY from $1000.0 in Q1 2025.
Powered by 
Analysis
Viking Therapeutics (VKTX) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Viking Therapeutics has reported Exchange Rate Effect for 5 years, with the latest figure at $16000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 1500.0% year-over-year to $16000.0 in Q1 2026, while the trailing twelve-month figure through Jun 2026 was $19000.0 (up 116.67% YoY) and the FY2025 annual result came in at -$8000.0, up 94.59% from the prior year.
- Exchange Rate Effect improved to $16000.0 in Q1 2026 per VKTX's latest filing, from $9000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $141000.0 in Q4 2022 and troughed at -$223000.0 in Q3 2022.
- A 5-year average of -$16800.0 and a median of -$6000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect sank 500.0% in 2025, then soared 1500.0% in 2026.
- Over 5 years, Exchange Rate Effect stood at $141000.0 in 2022, then sank by 64.54% to $50000.0 in 2023, then sank by 248.0% to -$74000.0 in 2024, then jumped by 112.16% to $9000.0 in 2025, then jumped by 77.78% to $16000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $16000.0, $9000.0, and -$6000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -287,000.00 |
| 10 | Viking Therapeutics | 4.00 Bn | 4.00 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 16,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | -74,000.00 |
| Sep 30, 2024 | -29,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | -48,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | -68,000.00 |
| Jun 30, 2023 | -3,000.00 |
| Mar 31, 2023 | -9,000.00 |
| Dec 31, 2022 | 141,000.00 |
| Sep 30, 2022 | -223,000.00 |